Scope of the Report:

The global Genomic Biomarkers market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Genomic Biomarkers.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Genomic Biomarkers market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Genomic Biomarkers market by product type and applications/end industries.

Market Segment by Companies, this report covers

Thermo Fisher Scientific

F. Hoffmann-La Roche

Aepodia

Myriad Genetics

Eurofins Scientific

QIAGEN

Bio-Rad Laboratories

Genomic Health

Liquid Genomics

Epigenomics

AROS Applied Biotechnology A/S

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Oncology

Cardiovascular diseases

Neurological diseases

Others

Market Segment by Applications, can be divided into

Diagnostic and research laboratories

Hospitals

Others

Table of Contents

1 Genomic Biomarkers Market Overview

1.1 Product Overview and Scope of Genomic Biomarkers

1.2 Classification of Genomic Biomarkers by Types

1.2.1 Global Genomic Biomarkers Revenue Comparison by Types (2017-2023)

1.2.2 Global Genomic Biomarkers Revenue Market Share by Types in 2017

1.2.3 Oncology

1.2.4 Cardiovascular diseases

1.2.5 Neurological diseases

1.2.6 Others

1.3 Global Genomic Biomarkers Market by Application

1.3.1 Global Genomic Biomarkers Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Diagnostic and research laboratories

1.3.3 Hospitals

1.3.4 Others

1.4 Global Genomic Biomarkers Market by Regions

1.4.1 Global Genomic Biomarkers Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Genomic Biomarkers Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Genomic Biomarkers Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomic Biomarkers Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Genomic Biomarkers Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomic Biomarkers Status and Prospect (2013-2023)

1.5 Global Market Size of Genomic Biomarkers (2013-2023)

2 Manufacturers Profiles

2.1 Thermo Fisher Scientific

2.1.1 Business Overview

2.1.2 Genomic Biomarkers Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Thermo Fisher Scientific Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.2 F. Hoffmann-La Roche

2.2.1 Business Overview

2.2.2 Genomic Biomarkers Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 F. Hoffmann-La Roche Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.3 Aepodia

2.3.1 Business Overview

2.3.2 Genomic Biomarkers Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Aepodia Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.4 Myriad Genetics

2.4.1 Business Overview

2.4.2 Genomic Biomarkers Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Myriad Genetics Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.5 Eurofins Scientific

2.5.1 Business Overview

2.5.2 Genomic Biomarkers Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Eurofins Scientific Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.6 QIAGEN

2.6.1 Business Overview

2.6.2 Genomic Biomarkers Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 QIAGEN Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.7 Bio-Rad Laboratories

2.7.1 Business Overview

2.7.2 Genomic Biomarkers Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bio-Rad Laboratories Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.8 Genomic Health

2.8.1 Business Overview

2.8.2 Genomic Biomarkers Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Genomic Health Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.9 Liquid Genomics

2.9.1 Business Overview

2.9.2 Genomic Biomarkers Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Liquid Genomics Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.10 Epigenomics

2.10.1 Business Overview

2.10.2 Genomic Biomarkers Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Epigenomics Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

2.11 AROS Applied Biotechnology A/S

2.11.1 Business Overview

2.11.2 Genomic Biomarkers Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 AROS Applied Biotechnology A/S Genomic Biomarkers Revenue, Gross Margin and Market Share (2016-2017)

3 Global Genomic Biomarkers Market Competition, by Players

3.1 Global Genomic Biomarkers Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Genomic Biomarkers Players Market Share

3.2.2 Top 10 Genomic Biomarkers Players Market Share

3.3 Market Competition Trend

4 Global Genomic Biomarkers Market Size by Regions

4.1 Global Genomic Biomarkers Revenue and Market Share by Regions

4.2 North America Genomic Biomarkers Revenue and Growth Rate (2013-2018)

4.3 Europe Genomic Biomarkers Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Genomic Biomarkers Revenue and Growth Rate (2013-2018)

4.5 South America Genomic Biomarkers Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Genomic Biomarkers Revenue and Growth Rate (2013-2018)

5 North America Genomic Biomarkers Revenue by Countries

5.1 North America Genomic Biomarkers Revenue by Countries (2013-2018)

5.2 USA Genomic Biomarkers Revenue and Growth Rate (2013-2018)

5.3 Canada Genomic Biomarkers Revenue and Growth Rate (2013-2018)

5.4 Mexico Genomic Biomarkers Revenue and Growth Rate (2013-2018)

6 Europe Genomic Biomarkers Revenue by Countries

6.1 Europe Genomic Biomarkers Revenue by Countries (2013-2018)

6.2 Germany Genomic Biomarkers Revenue and Growth Rate (2013-2018)

6.3 UK Genomic Biomarkers Revenue and Growth Rate (2013-2018)

6.4 France Genomic Biomarkers Revenue and Growth Rate (2013-2018)

6.5 Russia Genomic Biomarkers Revenue and Growth Rate (2013-2018)

6.6 Italy Genomic Biomarkers Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Genomic Biomarkers Revenue by Countries

7.1 Asia-Pacific Genomic Biomarkers Revenue by Countries (2013-2018)

7.2 China Genomic Biomarkers Revenue and Growth Rate (2013-2018)

7.3 Japan Genomic Biomarkers Revenue and Growth Rate (2013-2018)

7.4 Korea Genomic Biomarkers Revenue and Growth Rate (2013-2018)

7.5 India Genomic Biomarkers Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Genomic Biomarkers Revenue and Growth Rate (2013-2018)

8 South America Genomic Biomarkers Revenue by Countries

8.1 South America Genomic Biomarkers Revenue by Countries (2013-2018)

8.2 Brazil Genomic Biomarkers Revenue and Growth Rate (2013-2018)

8.3 Argentina Genomic Biomarkers Revenue and Growth Rate (2013-2018)

8.4 Colombia Genomic Biomarkers Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Genomic Biomarkers by Countries

9.1 Middle East and Africa Genomic Biomarkers Revenue by Countries (2013-2018)

9.2 Saudi Arabia Genomic Biomarkers Revenue and Growth Rate (2013-2018)

9.3 UAE Genomic Biomarkers Revenue and Growth Rate (2013-2018)

9.4 Egypt Genomic Biomarkers Revenue and Growth Rate (2013-2018)

9.5 Nigeria Genomic Biomarkers Revenue and Growth Rate (2013-2018)

9.6 South Africa Genomic Biomarkers Revenue and Growth Rate (2013-2018)

10 Global Genomic Biomarkers Market Segment by Type

10.1 Global Genomic Biomarkers Revenue and Market Share by Type (2013-2018)

10.2 Global Genomic Biomarkers Market Forecast by Type (2018-2023)

10.3 Oncology Revenue Growth Rate (2013-2023)

10.4 Cardiovascular diseases Revenue Growth Rate (2013-2023)

10.5 Neurological diseases Revenue Growth Rate (2013-2023)

10.6 Others Revenue Growth Rate (2013-2023)

11 Global Genomic Biomarkers Market Segment by Application

11.1 Global Genomic Biomarkers Revenue Market Share by Application (2013-2018)

11.2 Genomic Biomarkers Market Forecast by Application (2018-2023)

11.3 Diagnostic and research laboratories Revenue Growth (2013-2018)

11.4 Hospitals Revenue Growth (2013-2018)

11.5 Others Revenue Growth (2013-2018)

12 Global Genomic Biomarkers Market Size Forecast (2018-2023)

12.1 Global Genomic Biomarkers Market Size Forecast (2018-2023)

12.2 Global Genomic Biomarkers Market Forecast by Regions (2018-2023)

12.3 North America Genomic Biomarkers Revenue Market Forecast (2018-2023)

12.4 Europe Genomic Biomarkers Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Genomic Biomarkers Revenue Market Forecast (2018-2023)

12.6 South America Genomic Biomarkers Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Genomic Biomarkers Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Genomic Biomarkers Picture

Table Product Specifications of Genomic Biomarkers

Table Global Genomic Biomarkers and Revenue (Million USD) Market Split by Product Type<